From the Apolipoprotein MOrtality RISk (AMORIS) study with repeated measurements of CRP in a prospective cohort study noted a positive trend between CRP and risk of developing prostate cancer and concluded a link between inflammatory markers and cancer risk [ 53 ]. 10.
← all excerpts
Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer.
1
—
—